• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[三组人血清中抗新型隐球菌抗体的检测]

[Detection of anti-Cryptococcus neoformans antibodies in 3 groups of human sera].

作者信息

Martínez Machín G, Alvarez Bernal L P, Fernández Andreu C, Llop Hernández A

机构信息

Instituto de Medicina Tropical Pedro Kouri Laboratorio de Micologia.

出版信息

Rev Cubana Med Trop. 1992;44(2):141-4.

PMID:9768206
Abstract

The tube agglutination (TA) technique was normalized in order to determine anti-Cryptococcus neoformans antibodies, according to Palmer et al., by employing positive and negative control sera and an antigenic suspension prepared from an autochtonous strain of Cryptococcus neoformans varneofornnans. Three groups of human sera were studied and the role of TA in detecting antibodies in the group of sera from patients with active cryptococcosis (100%) was shown. In sera from banks positiveness was only 6%, while in the group of fowl breeders, considered to be "exposed", positiveness was found to be 16%, although with low titres. A discussion is carried out about the value of this technique as a complement in the diagnosis and prognosis of cryptococcosis.

摘要

为了检测抗新型隐球菌抗体,根据帕尔默等人的方法,采用阳性和阴性对照血清以及由一株新型隐球菌变种新形隐球菌的本地菌株制备的抗原悬液,对试管凝集(TA)技术进行了标准化。研究了三组人血清,并显示了TA在检测活动性隐球菌病患者血清组中抗体的作用(100%)。在血库血清中阳性率仅为6%,而在被认为“暴露”的家禽饲养者组中,阳性率为16%,尽管滴度较低。文中对该技术作为隐球菌病诊断和预后补充手段的价值进行了讨论。

相似文献

1
[Detection of anti-Cryptococcus neoformans antibodies in 3 groups of human sera].[三组人血清中抗新型隐球菌抗体的检测]
Rev Cubana Med Trop. 1992;44(2):141-4.
2
Analysis of antibody response to Cryptococcus neoformans in five patients with AIDS and cryptococcosis by immunoblotting.通过免疫印迹法分析5例艾滋病合并隐球菌病患者对新型隐球菌的抗体反应。
J Infect. 2000 Jan;40(1):64-8. doi: 10.1053/jinf.1999.0592.
3
Anti-glucuronoxylomannan IgG1 specific antibodies production in Cryptococcus neoformans resistant mice.新型隐球菌抗性小鼠中抗葡糖醛酸木甘露聚糖IgG1特异性抗体的产生
Biomedica. 2005 Mar;25(1):110-9.
4
Efficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannan.用人免疫球蛋白转基因小鼠免疫,使其产生针对新型隐球菌葡糖醛酸木聚糖甘露聚糖肽模拟表位的免疫血清的功效。
Vaccine. 2004 Sep 28;22(29-30):4062-8. doi: 10.1016/j.vaccine.2004.03.060.
5
[Isolation of anti-Cryptococcus neoformans immunoglobulin G].[抗新型隐球菌免疫球蛋白G的分离]
Rev Cubana Med Trop. 1998;50(1):27-30.
6
Towards a vaccine for Cryptococcus neoformans: principles and caveats.迈向新型隐球菌疫苗:原理与注意事项。
FEMS Yeast Res. 2006 Jun;6(4):525-36. doi: 10.1111/j.1567-1364.2006.00073.x.
7
Heat shock protein 70 (hsp70) as a major target of the antibody response in patients with pulmonary cryptococcosis.热休克蛋白70(hsp70)作为肺隐球菌病患者抗体反应的主要靶点。
Clin Exp Immunol. 1999 Mar;115(3):485-90. doi: 10.1046/j.1365-2249.1999.00821.x.
8
[The evaluation of the specific type of capsular polysaccharide of Cryptococcus neoformans as an immunogen and positive-control antigen].[新型隐球菌特定类型荚膜多糖作为免疫原和阳性对照抗原的评估]
Rev Cubana Med Trop. 1998;50(3):207-8.
9
Serologic evidence for Cryptococcus neoformans infection in early childhood.儿童期早期新型隐球菌感染的血清学证据。
Pediatrics. 2001 May;107(5):E66. doi: 10.1542/peds.107.5.e66.
10
[Cryptococcus].[隐球菌]
Nihon Rinsho. 1999 Nov;57 Suppl:223-6.